The Valley Desk

NCT02728258 · Interventional trial

Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Overall registry status Completed

Phase 2

Conditions Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Undifferentiated Carcinoma, Metastatic Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov